搜索临床试验以：阿帕替尼、Camrelizumab、化疗（吉西他滨/卡培他滨/多西紫杉醇）
总计107个结果
-
The First Affiliated Hospital of Zhengzhou University招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.招聘中
-
Zhou FuxiangHubei Cancer Hospital; Henan Provincial People's Hospital; Huangshi Central Hospital, China招聘中
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.招聘中
-
Sun Yat-sen UniversityPeking University; Zhejiang Cancer Hospital; Xiangya Hospital of Central South University; Henan... 和其他合作者尚未招聘
-
Peking University People's HospitalChinese Sarcoma Study Group招聘中
-
Latin American Cooperative Oncology GroupGlaxoSmithKline完全的管理系统1 | 开始研究的绩效状态为零到二 | 接受最多一次化疗的患者 | 紫杉烷类药物后进展的患者阿根廷, 巴西, 秘鲁
-
Wuhan University招聘中
-
First Affiliated Hospital of Zhejiang University尚未招聘
-
Eli Lilly and Company完全的
-
Columbia UniversitySanofi完全的
-
Novartis Pharmaceuticals完全的乳腺癌印度, 马来西亚, 沙特阿拉伯, 台湾, 俄罗斯联邦, 黎巴嫩, 南非, 泰国, 约旦, 火鸡, 埃及, 越南, 新加坡
-
University of NebraskaNational Cancer Institute (NCI)完全的
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)撤销
-
Shanghai Ninth People's Hospital Affiliated to...招聘中
-
AstraZeneca招聘中
-
The First Hospital of Jilin University未知
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University尚未招聘
-
Fudan UniversityNanfang Hospital of Southern Medical University; Ningbo Medical Center Lihuili Hospital; Shenzhen... 和其他合作者招聘中
-
Jiangsu Alphamab Biopharmaceuticals Co., Ltd尚未招聘
-
Hunan Cancer HospitalSuzhou Sheng Diya Biomedical Co., Ltd.主动，不招人